AYTU BIOPHARMA, INC Interest Income (Expense), Nonoperating, Net
AYTU BIOPHARMA, INC (AYTU) reported Interest Income (Expense), Nonoperating, Net of -$425.43 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2021-05-17
- AYTU BIOPHARMA, INC interest income (expense), nonoperating, net for the quarter ending 2021-03-31 was -$425.43K.
- AYTU BIOPHARMA, INC interest income (expense), nonoperating, net for the quarter ending 2020-12-31 was -$378.96K.
- AYTU BIOPHARMA, INC interest income (expense), nonoperating, net for the quarter ending 2020-03-31 was -$538.86K.
- AYTU BIOPHARMA, INC interest income (expense), nonoperating, net for the quarter ending 2019-12-31 was -$446.96K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month |
|---|---|---|---|
| 2021-03-31 | -$425.43K 10-Q · filed 2021-05-17 | -$804.38K derived: sum of 2 quarters · filed 2021-05-17 | -$1.56M 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$378.96K 10-Q · filed 2021-02-11 | -$1.13M 10-Q · filed 2021-02-11 | |
| 2020-03-31 | -$538.86K 10-Q · filed 2021-05-17 | -$985.82K derived: sum of 2 quarters · filed 2021-05-17 | -$1.18M 10-Q · filed 2021-05-17 |
| 2019-12-31 | -$446.96K 10-Q · filed 2021-02-11 | -$642.34K 10-Q · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |